0
0
ATLANTA — In a landmark decision that overturns more than three decades of public health practice, the U.S. Centers for Disease Control and Prevention (CDC) formally announced on Tuesday, December 16, 2025, that it will no longer recommend a universal Hepatitis B vaccine dose for all newborns at birth.
The new policy, signed by Acting CDC Director and Deputy Secretary of Health and Human Services Jim O’Neill, advises that for infants born to mothers who test negative for Hepatitis B, the decision to vaccinate at birth should now be subject to “individual-based decision-making.” Under the new guidelines, if parents opt out of the birth dose, the vaccination series is recommended to begin no earlier than two months of age.
The move marks a significant departure from the strategy in place since 1991, which health officials credit with a 99% reduction in serious Hepatitis B infections among American children.
A Shift to “Informed Consent”
The policy change follows an 8-3 vote by the Advisory Committee on Immunization Practices (ACIP), a federal panel recently reconstituted by Health and Human Services Secretary Robert F. Kennedy Jr.
Proponents of the change argued that the risk of Hepatitis B transmission to infants born to uninfected mothers is negligible, rendering the universal birth dose unnecessary.
“We are restoring the balance of informed consent to parents whose newborns face little risk of contracting hepatitis B,” said Jim O’Neill in a statement following the approval.
During the ACIP meetings leading up to the vote, committee member Retsef Levi, a professor of operations management at MIT, characterized the universal recommendation as forcing newborns to serve as “a safety net for adults’ mistakes.” The committee also heard presentations from researchers who argued that the decline in Hepatitis B cases could be attributed to factors other than the birth dose, such as better blood screening.
Crucially, the new guidance maintains the recommendation for immediate vaccination and immune globulin for infants born to mothers who test positive for Hepatitis B or whose infection status is unknown—a group at high risk for chronic infection and liver failure.
Medical Community Raises Alarm
The decision has triggered immediate and sharp criticism from major medical organizations, including the American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP). Health experts warn that removing the universal birth dose dismantling a critical safety net, citing the fallibility of testing and the asymptomatic nature of the virus.
Dr. Cody Meissner, a pediatrician and infectious disease expert at Dartmouth College who sits on the ACIP, voted against the recommendation. In a dissenting comment during the meeting, he challenged the scientific basis of the reversal.
“Thoughtful inquiry is always commendable,” Dr. Meissner told the committee. “But that inquiry should not be confused with baseless skepticism, which is what I think we’re encountering here.”
Dr. Sandra Fryhofer, a liaison for the American Medical Association (AMA), emphasized the practical dangers of the new policy. She noted that CDC data indicates approximately 50% of people living with Hepatitis B are unaware of their infection. Without the universal birth dose, an infant could be exposed to the virus by a household member or relative whose status is unknown.
“Are we going to test every patient that has access to or touches that baby?” Dr. Fryhofer asked. “That’s not something that’s really doable.”
Political and Structural Context
The policy shift occurs against a backdrop of significant changes at the federal health level. Secretary Kennedy, a longtime critic of previous vaccination policies, recently dismissed all prior members of the ACIP, replacing them with appointees who have expressed skepticism regarding established immunization schedules.
The ACIP meeting featured presentations from Aaron Siri, a vaccine injury lawyer who has represented Secretary Kennedy, and Cynthia Nevison, a researcher who has challenged the necessity of the birth dose.
Political reactions have been polarized. U.S. Senator Bill Cassidy (R-LA), a hepatologist (liver doctor) who previously treated Hepatitis B patients, publicly condemned the decision.
“As a liver doctor who has treated patients with hepatitis B for decades, this change to the vaccine schedule is a mistake,” Senator Cassidy wrote in a statement, calling the current ACIP panel “totally discredited.”
Implications for Families and Clinicians
For healthcare providers and parents, the “individual-based decision-making” model introduces new complexities to newborn care.
-
Logistical Challenges: Clinicians must now engage in detailed risk-benefit discussions with parents immediately after birth, a time often filled with exhaustion and overwhelming information.
-
Risk of Errors: Critics worry that if a mother’s test result is a false negative, or if it is transcribed incorrectly in medical records, a newborn could miss the critical window for prevention. Hepatitis B is 90% likely to become chronic if contracted in infancy, often leading to cirrhosis or liver cancer later in life.
-
Access Concerns: While federal programs like Vaccines for Children (VFC) will still cover the vaccine for eligible families who choose it, state health officials have expressed concern that the lack of a “routine” recommendation could lead to access barriers or insurance disputes in the future.
Dr. Natasha Bagdasarian, representing the Association of State and Territorial Health Officials, warned that the new language “muddies the waters, creates a false sense of scientific uncertainty, and places unnecessary burden on clinicians and families.”
Looking Ahead
The revised schedule is expected to be implemented in early 2026. While the CDC sets federal recommendations, state health departments hold the authority to determine school and daycare entry requirements, potentially setting up a patchwork of vaccination mandates across the country.
As the debate continues, health experts advise parents to have open conversations with their pediatricians.
“The hepatitis B vaccine is safe and effective,” Senator Cassidy noted. “The birth dose is a recommendation, NOT a mandate, [but] it protects children.”
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
Official Policy Announcements:
-
Centers for Disease Control and Prevention (CDC). “CDC Adopts Individual-Based Decision-Making for Hepatitis B Immunization.” Press Release, December 16, 2025.
